US2003166610A1PendingUtilityA1
Nutritional composition
Priority: Jul 24, 2000Filed: Jan 24, 2003Published: Sep 4, 2003
Est. expiryJul 24, 2020(expired)· nominal 20-yr term from priority
A61K 31/70A23L 33/22A61K 31/715A23L 29/25A23L 29/30A23L 33/10A23V 2002/00A23L 29/244A61P 43/00A61P 31/04A61P 1/12A61P 1/00A23L 5/00A23L 33/125
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A nutritional composition is disclosed which comprises synergistic functional carbohydrates for preventing or treating infection by pathogenic bacteria and/or promoting gut flora balance and health. The carbohydrates have a synergistic activity on promoting bifidobacteria in the intestine. Also disclosed are a method of production of the composition; and a method of treatment of infection by pathogenic bacteria and/or promoting gut flora balance and health which comprises administering an effective amount of the composition.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A nutritional composition for the prevention or treatment of infection by pathogenic bacteria and/or for the promotion of gut flora balance and health which comprises at least two synergistic functional carbohydrates wherein a first carbohydrate is selected from the group which consists of inulin and fructooligosaccharide (FOS), and a second carbohydrate is selected from the group which consists of xylooligosaccharide (XOS), acacia gum and resistant starch, in amounts effective to stimulate intestinal bifidobacteria, and thus promote associated health benefits.
2 . The nutritional composition according to claim 1 wherein the first carbohydrate comprises inulin.
3 . The nutritional composition according to claim 1 , wherein the first carbohydrate comprises fructooligosaccharide as said first carbohydrate and wherein the second carbohydrate is selected from the group which consists of xylooligosaccharide and acacia gum.
4 . The nutritional composition according to claim 1 , wherein the first carbohydrate comprises fructooligosaccharide and the second carbohydrate comprises acacia gum.
5 . The nutritional composition according to claim 1 , wherein a ratio of the first and the second carbohydrates by weight is 1-20:0.1-20.
6 . An edible composition which is formulated for human or companion animal consumption and/or administration, comprising a food, food-forming, beverage, or beverage-forming component and the nutritional composition of claim 1 .
7 . The edible composition of claim 6 in the form of a powder or liquid concentrate.
8 . The edible composition of claim 6 wherein the first carbohydrate is present in an amount of about 1 g to about 20 g, and the second carbohydrate is present in an amount of about 0.1 g to about 20 g.
9 . The edible composition according to claim 8 , wherein the first and the second carbohydrates are present in a weight ratio of 1-20:0.1-20.
10 . The edible composition of claim 6 further comprising a fat source that provides about 5% to about 55% of the energy of the nutritional formula.
11 . The edible composition of claim 9 , wherein the fat source is a vegetable fat or animal fat.
12 . The edible composition of claim 6 , further comprising one or more of a protein source, a fat source, an additional carbohydrate source, an additional dietary fiber, a vitamin, a mineral or a food grade emulsifier.
13 . The edible composition of claim 6 which contains milk.
14 . A method of producing the nutritional composition of claim 1 , which comprises blending the first and second carbohydrates in required amounts to form the composition.
15 . A method of treating an infection by pathogenic bacteria and/or promoting gut flora balance and health, which comprises administering an amount of the nutritional composition of claim 1 effective to stimulate intestinal bifidobacteria and thus promote associated health benefits.
16 . A method of reducing side effects of consuming fiber, which comprises administering fiber in combination with the nutritional composition of claim 1 .
17 . A method of preventing or treating the Irritable Bowel Syndrome (IBS), which comprises administering an amount of the nutritional composition of claim 1 effective to stimulate intestinal bifidobacteria and thus prevent or treat the IBS.Join the waitlist — get patent alerts
Track US2003166610A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.